The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antithyroid Drug Market Research Report 2024
Synopsis
Antithyroid drug is a drug for the treatment of hyperthyroidism. It mainly reduces the secretion of thyroid hormone by inhibiting thyroid synthesis.
The global Antithyroid Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antithyroid Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithyroid Drug.
Report Scope
The Antithyroid Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antithyroid Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antithyroid Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai Huanghai Pharmaceutical Co., Ltd
Merck KGaA
Lomapharm Rudolf Lohmann GmbH KG
Herbrand Pharmaceutical Chemistry Co., Ltd
Beijing Tongjida Pharmaceutical Co., Ltd
Shanghai Zhaohui Pharmaceutical Co., Ltd
Guangzhou Kanghe Pharmaceutical Co., Ltd
Hunan Hansen Pharmaceutical Co., Ltd
World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
Haimani Pharmaceutical Co., Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Amgen Inc
AbbVie Deutschland GmbH & Co.KG
Centrix Pharmaceutical Inc.
Pfizer Inc.
Actavis Totowa LLC
Caraco Pharmaceutical Laboratories
Boca Pharmacal Inc.
Heritage Pharmaceuticals Inc.
Par Pharmaceutical Inc
Sandoz Pharmaceuticals Inc.
Segment by Type
Thiourea
Iodine and Iodide
Radioiodine
β Receptor Blockers
Segment by Application
Medical Treatment of Hyperthyroidism
Preparation for Thyroid Surgery
Treatment of Thyroid Crisis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antithyroid Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antithyroid drug is a drug for the treatment of hyperthyroidism. It mainly reduces the secretion of thyroid hormone by inhibiting thyroid synthesis.
The global Antithyroid Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antithyroid Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithyroid Drug.
Report Scope
The Antithyroid Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antithyroid Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antithyroid Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai Huanghai Pharmaceutical Co., Ltd
Merck KGaA
Lomapharm Rudolf Lohmann GmbH KG
Herbrand Pharmaceutical Chemistry Co., Ltd
Beijing Tongjida Pharmaceutical Co., Ltd
Shanghai Zhaohui Pharmaceutical Co., Ltd
Guangzhou Kanghe Pharmaceutical Co., Ltd
Hunan Hansen Pharmaceutical Co., Ltd
World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
Haimani Pharmaceutical Co., Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Amgen Inc
AbbVie Deutschland GmbH & Co.KG
Centrix Pharmaceutical Inc.
Pfizer Inc.
Actavis Totowa LLC
Caraco Pharmaceutical Laboratories
Boca Pharmacal Inc.
Heritage Pharmaceuticals Inc.
Par Pharmaceutical Inc
Sandoz Pharmaceuticals Inc.
Segment by Type
Thiourea
Iodine and Iodide
Radioiodine
β Receptor Blockers
Segment by Application
Medical Treatment of Hyperthyroidism
Preparation for Thyroid Surgery
Treatment of Thyroid Crisis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antithyroid Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antithyroid Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Thiourea
1.2.3 Iodine and Iodide
1.2.4 Radioiodine
1.2.5 β Receptor Blockers
1.3 Market by Application
1.3.1 Global Antithyroid Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Treatment of Hyperthyroidism
1.3.3 Preparation for Thyroid Surgery
1.3.4 Treatment of Thyroid Crisis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antithyroid Drug Market Perspective (2019-2030)
2.2 Antithyroid Drug Growth Trends by Region
2.2.1 Global Antithyroid Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antithyroid Drug Historic Market Size by Region (2019-2024)
2.2.3 Antithyroid Drug Forecasted Market Size by Region (2025-2030)
2.3 Antithyroid Drug Market Dynamics
2.3.1 Antithyroid Drug Industry Trends
2.3.2 Antithyroid Drug Market Drivers
2.3.3 Antithyroid Drug Market Challenges
2.3.4 Antithyroid Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antithyroid Drug Players by Revenue
3.1.1 Global Top Antithyroid Drug Players by Revenue (2019-2024)
3.1.2 Global Antithyroid Drug Revenue Market Share by Players (2019-2024)
3.2 Global Antithyroid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antithyroid Drug Revenue
3.4 Global Antithyroid Drug Market Concentration Ratio
3.4.1 Global Antithyroid Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antithyroid Drug Revenue in 2023
3.5 Antithyroid Drug Key Players Head office and Area Served
3.6 Key Players Antithyroid Drug Product Solution and Service
3.7 Date of Enter into Antithyroid Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antithyroid Drug Breakdown Data by Type
4.1 Global Antithyroid Drug Historic Market Size by Type (2019-2024)
4.2 Global Antithyroid Drug Forecasted Market Size by Type (2025-2030)
5 Antithyroid Drug Breakdown Data by Application
5.1 Global Antithyroid Drug Historic Market Size by Application (2019-2024)
5.2 Global Antithyroid Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antithyroid Drug Market Size (2019-2030)
6.2 North America Antithyroid Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antithyroid Drug Market Size by Country (2019-2024)
6.4 North America Antithyroid Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antithyroid Drug Market Size (2019-2030)
7.2 Europe Antithyroid Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antithyroid Drug Market Size by Country (2019-2024)
7.4 Europe Antithyroid Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antithyroid Drug Market Size (2019-2030)
8.2 Asia-Pacific Antithyroid Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antithyroid Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Antithyroid Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antithyroid Drug Market Size (2019-2030)
9.2 Latin America Antithyroid Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antithyroid Drug Market Size by Country (2019-2024)
9.4 Latin America Antithyroid Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antithyroid Drug Market Size (2019-2030)
10.2 Middle East & Africa Antithyroid Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antithyroid Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Antithyroid Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Huanghai Pharmaceutical Co., Ltd
11.1.1 Shanghai Huanghai Pharmaceutical Co., Ltd Company Detail
11.1.2 Shanghai Huanghai Pharmaceutical Co., Ltd Business Overview
11.1.3 Shanghai Huanghai Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.1.4 Shanghai Huanghai Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.1.5 Shanghai Huanghai Pharmaceutical Co., Ltd Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Antithyroid Drug Introduction
11.2.4 Merck KGaA Revenue in Antithyroid Drug Business (2019-2024)
11.2.5 Merck KGaA Recent Development
11.3 Lomapharm Rudolf Lohmann GmbH KG
11.3.1 Lomapharm Rudolf Lohmann GmbH KG Company Detail
11.3.2 Lomapharm Rudolf Lohmann GmbH KG Business Overview
11.3.3 Lomapharm Rudolf Lohmann GmbH KG Antithyroid Drug Introduction
11.3.4 Lomapharm Rudolf Lohmann GmbH KG Revenue in Antithyroid Drug Business (2019-2024)
11.3.5 Lomapharm Rudolf Lohmann GmbH KG Recent Development
11.4 Herbrand Pharmaceutical Chemistry Co., Ltd
11.4.1 Herbrand Pharmaceutical Chemistry Co., Ltd Company Detail
11.4.2 Herbrand Pharmaceutical Chemistry Co., Ltd Business Overview
11.4.3 Herbrand Pharmaceutical Chemistry Co., Ltd Antithyroid Drug Introduction
11.4.4 Herbrand Pharmaceutical Chemistry Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.4.5 Herbrand Pharmaceutical Chemistry Co., Ltd Recent Development
11.5 Beijing Tongjida Pharmaceutical Co., Ltd
11.5.1 Beijing Tongjida Pharmaceutical Co., Ltd Company Detail
11.5.2 Beijing Tongjida Pharmaceutical Co., Ltd Business Overview
11.5.3 Beijing Tongjida Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.5.4 Beijing Tongjida Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.5.5 Beijing Tongjida Pharmaceutical Co., Ltd Recent Development
11.6 Shanghai Zhaohui Pharmaceutical Co., Ltd
11.6.1 Shanghai Zhaohui Pharmaceutical Co., Ltd Company Detail
11.6.2 Shanghai Zhaohui Pharmaceutical Co., Ltd Business Overview
11.6.3 Shanghai Zhaohui Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.6.4 Shanghai Zhaohui Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.6.5 Shanghai Zhaohui Pharmaceutical Co., Ltd Recent Development
11.7 Guangzhou Kanghe Pharmaceutical Co., Ltd
11.7.1 Guangzhou Kanghe Pharmaceutical Co., Ltd Company Detail
11.7.2 Guangzhou Kanghe Pharmaceutical Co., Ltd Business Overview
11.7.3 Guangzhou Kanghe Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.7.4 Guangzhou Kanghe Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.7.5 Guangzhou Kanghe Pharmaceutical Co., Ltd Recent Development
11.8 Hunan Hansen Pharmaceutical Co., Ltd
11.8.1 Hunan Hansen Pharmaceutical Co., Ltd Company Detail
11.8.2 Hunan Hansen Pharmaceutical Co., Ltd Business Overview
11.8.3 Hunan Hansen Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.8.4 Hunan Hansen Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.8.5 Hunan Hansen Pharmaceutical Co., Ltd Recent Development
11.9 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd
11.9.1 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Company Detail
11.9.2 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Business Overview
11.9.3 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Antithyroid Drug Introduction
11.9.4 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.9.5 World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Recent Development
11.10 Haimani Pharmaceutical Co., Ltd
11.10.1 Haimani Pharmaceutical Co., Ltd Company Detail
11.10.2 Haimani Pharmaceutical Co., Ltd Business Overview
11.10.3 Haimani Pharmaceutical Co., Ltd Antithyroid Drug Introduction
11.10.4 Haimani Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.10.5 Haimani Pharmaceutical Co., Ltd Recent Development
11.11 Shanghai McLin Biochemical Technology Co., Ltd
11.11.1 Shanghai McLin Biochemical Technology Co., Ltd Company Detail
11.11.2 Shanghai McLin Biochemical Technology Co., Ltd Business Overview
11.11.3 Shanghai McLin Biochemical Technology Co., Ltd Antithyroid Drug Introduction
11.11.4 Shanghai McLin Biochemical Technology Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.11.5 Shanghai McLin Biochemical Technology Co., Ltd Recent Development
11.12 Shanghai Yuanye Bio-Technology Co., Ltd
11.12.1 Shanghai Yuanye Bio-Technology Co., Ltd Company Detail
11.12.2 Shanghai Yuanye Bio-Technology Co., Ltd Business Overview
11.12.3 Shanghai Yuanye Bio-Technology Co., Ltd Antithyroid Drug Introduction
11.12.4 Shanghai Yuanye Bio-Technology Co., Ltd Revenue in Antithyroid Drug Business (2019-2024)
11.12.5 Shanghai Yuanye Bio-Technology Co., Ltd Recent Development
11.13 Amgen Inc
11.13.1 Amgen Inc Company Detail
11.13.2 Amgen Inc Business Overview
11.13.3 Amgen Inc Antithyroid Drug Introduction
11.13.4 Amgen Inc Revenue in Antithyroid Drug Business (2019-2024)
11.13.5 Amgen Inc Recent Development
11.14 AbbVie Deutschland GmbH & Co.KG
11.14.1 AbbVie Deutschland GmbH & Co.KG Company Detail
11.14.2 AbbVie Deutschland GmbH & Co.KG Business Overview
11.14.3 AbbVie Deutschland GmbH & Co.KG Antithyroid Drug Introduction
11.14.4 AbbVie Deutschland GmbH & Co.KG Revenue in Antithyroid Drug Business (2019-2024)
11.14.5 AbbVie Deutschland GmbH & Co.KG Recent Development
11.15 Centrix Pharmaceutical Inc.
11.15.1 Centrix Pharmaceutical Inc. Company Detail
11.15.2 Centrix Pharmaceutical Inc. Business Overview
11.15.3 Centrix Pharmaceutical Inc. Antithyroid Drug Introduction
11.15.4 Centrix Pharmaceutical Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.15.5 Centrix Pharmaceutical Inc. Recent Development
11.16 Pfizer Inc.
11.16.1 Pfizer Inc. Company Detail
11.16.2 Pfizer Inc. Business Overview
11.16.3 Pfizer Inc. Antithyroid Drug Introduction
11.16.4 Pfizer Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.16.5 Pfizer Inc. Recent Development
11.17 Actavis Totowa LLC
11.17.1 Actavis Totowa LLC Company Detail
11.17.2 Actavis Totowa LLC Business Overview
11.17.3 Actavis Totowa LLC Antithyroid Drug Introduction
11.17.4 Actavis Totowa LLC Revenue in Antithyroid Drug Business (2019-2024)
11.17.5 Actavis Totowa LLC Recent Development
11.18 Caraco Pharmaceutical Laboratories
11.18.1 Caraco Pharmaceutical Laboratories Company Detail
11.18.2 Caraco Pharmaceutical Laboratories Business Overview
11.18.3 Caraco Pharmaceutical Laboratories Antithyroid Drug Introduction
11.18.4 Caraco Pharmaceutical Laboratories Revenue in Antithyroid Drug Business (2019-2024)
11.18.5 Caraco Pharmaceutical Laboratories Recent Development
11.19 Boca Pharmacal Inc.
11.19.1 Boca Pharmacal Inc. Company Detail
11.19.2 Boca Pharmacal Inc. Business Overview
11.19.3 Boca Pharmacal Inc. Antithyroid Drug Introduction
11.19.4 Boca Pharmacal Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.19.5 Boca Pharmacal Inc. Recent Development
11.20 Heritage Pharmaceuticals Inc.
11.20.1 Heritage Pharmaceuticals Inc. Company Detail
11.20.2 Heritage Pharmaceuticals Inc. Business Overview
11.20.3 Heritage Pharmaceuticals Inc. Antithyroid Drug Introduction
11.20.4 Heritage Pharmaceuticals Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.20.5 Heritage Pharmaceuticals Inc. Recent Development
11.21 Par Pharmaceutical Inc
11.21.1 Par Pharmaceutical Inc Company Detail
11.21.2 Par Pharmaceutical Inc Business Overview
11.21.3 Par Pharmaceutical Inc Antithyroid Drug Introduction
11.21.4 Par Pharmaceutical Inc Revenue in Antithyroid Drug Business (2019-2024)
11.21.5 Par Pharmaceutical Inc Recent Development
11.22 Sandoz Pharmaceuticals Inc.
11.22.1 Sandoz Pharmaceuticals Inc. Company Detail
11.22.2 Sandoz Pharmaceuticals Inc. Business Overview
11.22.3 Sandoz Pharmaceuticals Inc. Antithyroid Drug Introduction
11.22.4 Sandoz Pharmaceuticals Inc. Revenue in Antithyroid Drug Business (2019-2024)
11.22.5 Sandoz Pharmaceuticals Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Antithyroid Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Thiourea
Table 3. Key Players of Iodine and Iodide
Table 4. Key Players of Radioiodine
Table 5. Key Players of β Receptor Blockers
Table 6. Global Antithyroid Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Antithyroid Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Antithyroid Drug Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Antithyroid Drug Market Share by Region (2019-2024)
Table 10. Global Antithyroid Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Antithyroid Drug Market Share by Region (2025-2030)
Table 12. Antithyroid Drug Market Trends
Table 13. Antithyroid Drug Market Drivers
Table 14. Antithyroid Drug Market Challenges
Table 15. Antithyroid Drug Market Restraints
Table 16. Global Antithyroid Drug Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Antithyroid Drug Market Share by Players (2019-2024)
Table 18. Global Top Antithyroid Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithyroid Drug as of 2023)
Table 19. Ranking of Global Top Antithyroid Drug Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Antithyroid Drug Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antithyroid Drug Product Solution and Service
Table 23. Date of Enter into Antithyroid Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antithyroid Drug Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Antithyroid Drug Revenue Market Share by Type (2019-2024)
Table 27. Global Antithyroid Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Antithyroid Drug Revenue Market Share by Type (2025-2030)
Table 29. Global Antithyroid Drug Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Antithyroid Drug Revenue Market Share by Application (2019-2024)
Table 31. Global Antithyroid Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Antithyroid Drug Revenue Market Share by Application (2025-2030)
Table 33. North America Antithyroid Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Antithyroid Drug Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Antithyroid Drug Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Antithyroid Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Antithyroid Drug Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Antithyroid Drug Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Antithyroid Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Antithyroid Drug Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Antithyroid Drug Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Antithyroid Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Antithyroid Drug Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Antithyroid Drug Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Antithyroid Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Antithyroid Drug Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Antithyroid Drug Market Size by Country (2025-2030) & (US$ Million)
Table 48. Shanghai Huanghai Pharmaceutical Co., Ltd Company Detail
Table 49. Shanghai Huanghai Pharmaceutical Co., Ltd Business Overview
Table 50. Shanghai Huanghai Pharmaceutical Co., Ltd Antithyroid Drug Product
Table 51. Shanghai Huanghai Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 52. Shanghai Huanghai Pharmaceutical Co., Ltd Recent Development
Table 53. Merck KGaA Company Detail
Table 54. Merck KGaA Business Overview
Table 55. Merck KGaA Antithyroid Drug Product
Table 56. Merck KGaA Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 57. Merck KGaA Recent Development
Table 58. Lomapharm Rudolf Lohmann GmbH KG Company Detail
Table 59. Lomapharm Rudolf Lohmann GmbH KG Business Overview
Table 60. Lomapharm Rudolf Lohmann GmbH KG Antithyroid Drug Product
Table 61. Lomapharm Rudolf Lohmann GmbH KG Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 62. Lomapharm Rudolf Lohmann GmbH KG Recent Development
Table 63. Herbrand Pharmaceutical Chemistry Co., Ltd Company Detail
Table 64. Herbrand Pharmaceutical Chemistry Co., Ltd Business Overview
Table 65. Herbrand Pharmaceutical Chemistry Co., Ltd Antithyroid Drug Product
Table 66. Herbrand Pharmaceutical Chemistry Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 67. Herbrand Pharmaceutical Chemistry Co., Ltd Recent Development
Table 68. Beijing Tongjida Pharmaceutical Co., Ltd Company Detail
Table 69. Beijing Tongjida Pharmaceutical Co., Ltd Business Overview
Table 70. Beijing Tongjida Pharmaceutical Co., Ltd Antithyroid Drug Product
Table 71. Beijing Tongjida Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 72. Beijing Tongjida Pharmaceutical Co., Ltd Recent Development
Table 73. Shanghai Zhaohui Pharmaceutical Co., Ltd Company Detail
Table 74. Shanghai Zhaohui Pharmaceutical Co., Ltd Business Overview
Table 75. Shanghai Zhaohui Pharmaceutical Co., Ltd Antithyroid Drug Product
Table 76. Shanghai Zhaohui Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 77. Shanghai Zhaohui Pharmaceutical Co., Ltd Recent Development
Table 78. Guangzhou Kanghe Pharmaceutical Co., Ltd Company Detail
Table 79. Guangzhou Kanghe Pharmaceutical Co., Ltd Business Overview
Table 80. Guangzhou Kanghe Pharmaceutical Co., Ltd Antithyroid Drug Product
Table 81. Guangzhou Kanghe Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 82. Guangzhou Kanghe Pharmaceutical Co., Ltd Recent Development
Table 83. Hunan Hansen Pharmaceutical Co., Ltd Company Detail
Table 84. Hunan Hansen Pharmaceutical Co., Ltd Business Overview
Table 85. Hunan Hansen Pharmaceutical Co., Ltd Antithyroid Drug Product
Table 86. Hunan Hansen Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 87. Hunan Hansen Pharmaceutical Co., Ltd Recent Development
Table 88. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Company Detail
Table 89. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Business Overview
Table 90. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Antithyroid Drug Product
Table 91. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 92. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Recent Development
Table 93. Haimani Pharmaceutical Co., Ltd Company Detail
Table 94. Haimani Pharmaceutical Co., Ltd Business Overview
Table 95. Haimani Pharmaceutical Co., Ltd Antithyroid Drug Product
Table 96. Haimani Pharmaceutical Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 97. Haimani Pharmaceutical Co., Ltd Recent Development
Table 98. Shanghai McLin Biochemical Technology Co., Ltd Company Detail
Table 99. Shanghai McLin Biochemical Technology Co., Ltd Business Overview
Table 100. Shanghai McLin Biochemical Technology Co., Ltd Antithyroid Drug Product
Table 101. Shanghai McLin Biochemical Technology Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 102. Shanghai McLin Biochemical Technology Co., Ltd Recent Development
Table 103. Shanghai Yuanye Bio-Technology Co., Ltd Company Detail
Table 104. Shanghai Yuanye Bio-Technology Co., Ltd Business Overview
Table 105. Shanghai Yuanye Bio-Technology Co., Ltd Antithyroid Drug Product
Table 106. Shanghai Yuanye Bio-Technology Co., Ltd Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 107. Shanghai Yuanye Bio-Technology Co., Ltd Recent Development
Table 108. Amgen Inc Company Detail
Table 109. Amgen Inc Business Overview
Table 110. Amgen Inc Antithyroid Drug Product
Table 111. Amgen Inc Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 112. Amgen Inc Recent Development
Table 113. AbbVie Deutschland GmbH & Co.KG Company Detail
Table 114. AbbVie Deutschland GmbH & Co.KG Business Overview
Table 115. AbbVie Deutschland GmbH & Co.KG Antithyroid Drug Product
Table 116. AbbVie Deutschland GmbH & Co.KG Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 117. AbbVie Deutschland GmbH & Co.KG Recent Development
Table 118. Centrix Pharmaceutical Inc. Company Detail
Table 119. Centrix Pharmaceutical Inc. Business Overview
Table 120. Centrix Pharmaceutical Inc. Antithyroid Drug Product
Table 121. Centrix Pharmaceutical Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 122. Centrix Pharmaceutical Inc. Recent Development
Table 123. Pfizer Inc. Company Detail
Table 124. Pfizer Inc. Business Overview
Table 125. Pfizer Inc. Antithyroid Drug Product
Table 126. Pfizer Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 127. Pfizer Inc. Recent Development
Table 128. Actavis Totowa LLC Company Detail
Table 129. Actavis Totowa LLC Business Overview
Table 130. Actavis Totowa LLC Antithyroid Drug Product
Table 131. Actavis Totowa LLC Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 132. Actavis Totowa LLC Recent Development
Table 133. Caraco Pharmaceutical Laboratories Company Detail
Table 134. Caraco Pharmaceutical Laboratories Business Overview
Table 135. Caraco Pharmaceutical Laboratories Antithyroid Drug Product
Table 136. Caraco Pharmaceutical Laboratories Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 137. Caraco Pharmaceutical Laboratories Recent Development
Table 138. Boca Pharmacal Inc. Company Detail
Table 139. Boca Pharmacal Inc. Business Overview
Table 140. Boca Pharmacal Inc. Antithyroid Drug Product
Table 141. Boca Pharmacal Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 142. Boca Pharmacal Inc. Recent Development
Table 143. Heritage Pharmaceuticals Inc. Company Detail
Table 144. Heritage Pharmaceuticals Inc. Business Overview
Table 145. Heritage Pharmaceuticals Inc. Antithyroid Drug Product
Table 146. Heritage Pharmaceuticals Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 147. Heritage Pharmaceuticals Inc. Recent Development
Table 148. Par Pharmaceutical Inc Company Detail
Table 149. Par Pharmaceutical Inc Business Overview
Table 150. Par Pharmaceutical Inc Antithyroid Drug Product
Table 151. Par Pharmaceutical Inc Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 152. Par Pharmaceutical Inc Recent Development
Table 153. Sandoz Pharmaceuticals Inc. Company Detail
Table 154. Sandoz Pharmaceuticals Inc. Business Overview
Table 155. Sandoz Pharmaceuticals Inc. Antithyroid Drug Product
Table 156. Sandoz Pharmaceuticals Inc. Revenue in Antithyroid Drug Business (2019-2024) & (US$ Million)
Table 157. Sandoz Pharmaceuticals Inc. Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antithyroid Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antithyroid Drug Market Share by Type: 2023 VS 2030
Figure 3. Thiourea Features
Figure 4. Iodine and Iodide Features
Figure 5. Radioiodine Features
Figure 6. β Receptor Blockers Features
Figure 7. Global Antithyroid Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Antithyroid Drug Market Share by Application: 2023 VS 2030
Figure 9. Medical Treatment of Hyperthyroidism Case Studies
Figure 10. Preparation for Thyroid Surgery Case Studies
Figure 11. Treatment of Thyroid Crisis Case Studies
Figure 12. Antithyroid Drug Report Years Considered
Figure 13. Global Antithyroid Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Antithyroid Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Antithyroid Drug Market Share by Region: 2023 VS 2030
Figure 16. Global Antithyroid Drug Market Share by Players in 2023
Figure 17. Global Top Antithyroid Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithyroid Drug as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Antithyroid Drug Revenue in 2023
Figure 19. North America Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Antithyroid Drug Market Share by Country (2019-2030)
Figure 21. United States Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Antithyroid Drug Market Share by Country (2019-2030)
Figure 25. Germany Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Antithyroid Drug Market Share by Region (2019-2030)
Figure 33. China Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Antithyroid Drug Market Share by Country (2019-2030)
Figure 41. Mexico Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Antithyroid Drug Market Share by Country (2019-2030)
Figure 45. Turkey Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Antithyroid Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Shanghai Huanghai Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 48. Merck KGaA Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 49. Lomapharm Rudolf Lohmann GmbH KG Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 50. Herbrand Pharmaceutical Chemistry Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 51. Beijing Tongjida Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 52. Shanghai Zhaohui Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 53. Guangzhou Kanghe Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 54. Hunan Hansen Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 55. World Trade Tianjie Pharmaceutical (Jiangsu) Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 56. Haimani Pharmaceutical Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 57. Shanghai McLin Biochemical Technology Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 58. Shanghai Yuanye Bio-Technology Co., Ltd Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 59. Amgen Inc Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 60. AbbVie Deutschland GmbH & Co.KG Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 61. Centrix Pharmaceutical Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 62. Pfizer Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 63. Actavis Totowa LLC Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 64. Caraco Pharmaceutical Laboratories Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 65. Boca Pharmacal Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 66. Heritage Pharmaceuticals Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 67. Par Pharmaceutical Inc Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 68. Sandoz Pharmaceuticals Inc. Revenue Growth Rate in Antithyroid Drug Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
